Related Experiment Videos
[The treatment of hypertension with captopril]
Insights
Captopril effectively lowers blood pressure in severely hypertensive children within one hour. Long-term use offers sustained control for refractory cases with no observed side-effects.
Area of Science:
- Pediatric Nephrology
- Clinical Pharmacology
- Cardiovascular Medicine
Context:
- Severe hypertension in children presents significant clinical challenges.
- Limited treatment options exist for pediatric refractory hypertension.
- Assessing the efficacy and safety of angiotensin-converting enzyme inhibitors in pediatric populations is crucial.
Purpose:
- To evaluate the short-term and long-term efficacy of Captopril in severely hypertensive children.
- To determine the safety profile of Captopril in pediatric patients.
- To establish guidelines for Captopril use in acute and refractory pediatric hypertension.
Summary:
- A single dose of Captopril rapidly reduced blood pressure in severely hypertensive children, particularly those in a non-hypervolemic state.
- Long-term Captopril treatment (average 19 months) in five children with refractory hypertension achieved sustained blood pressure control.
- No adverse side-effects were reported during the study period for either short-term or long-term Captopril administration.
Impact:
- Captopril demonstrates utility as a treatment option for acute severe hypertension in pediatric patients.
- The findings support the use of Captopril for long-term management of refractory hypertension in children.
- This study contributes to evidence-based guidelines for managing pediatric hypertension with angiotensin-converting enzyme inhibitors.
Abstract:
Short term response to single dose of Captopril has been studied in 7 severely hypertensive children. Blood pressure fell within one hour in patients with a non-hypervolemic state. Longterm treatment (average 19 months) of 5 children with refractory hypertension resulted in a sustained blood pressure control. No side-effects had been observed. It is concluded, that Captopril is useful in children with acute severe hypertension. Longterm treatment should be limited to children with refractory hypertension.